The differential diagnosis of FLD and FED is limited to carriers of two mutant LCAT alleles and requires the distinct in vitro measurement of α-LCAT activity using a standardized exogenous HDL and the cholesterol esterification rate in plasma lipoproteins that include both α and β-LCAT activity [52]. Here, LCAT is linked to Familial LCAT deficiency.